- Home
- NKGN vs GIGM Comparison
NKGN vs GIGM Comparison
Compare NKGN & GIGM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NKGN
- GIGM
- Stock Information
- Founded
- NKGN 2017
- GIGM 1998
- Country
- NKGN United States
- GIGM Taiwan
- Employees
- NKGN N/A
- GIGM N/A
- Industry
- NKGN Biotechnology: Biological Products (No Diagnostic Substances)
- GIGM Computer Software: Programming Data Processing
- Sector
- NKGN Health Care
- GIGM Technology
- Exchange
- NKGN Nasdaq
- GIGM Nasdaq
- Market Cap
- NKGN 13.5M
- GIGM 14.5M
- IPO Year
- NKGN N/A
- GIGM 2000
- Fundamental
- Price
- NKGN $0.41
- GIGM $1.34
- Analyst Decision
- NKGN
- GIGM
- Analyst Count
- NKGN 0
- GIGM 0
- Target Price
- NKGN N/A
- GIGM N/A
- AVG Volume (30 Days)
- NKGN 388.3K
- GIGM 12.2K
- Earning Date
- NKGN 11-12-2024
- GIGM 10-29-2024
- Dividend Yield
- NKGN N/A
- GIGM N/A
- EPS Growth
- NKGN N/A
- GIGM N/A
- EPS
- NKGN N/A
- GIGM N/A
- Revenue
- NKGN N/A
- GIGM $3,387,000.00
- Revenue This Year
- NKGN N/A
- GIGM N/A
- Revenue Next Year
- NKGN N/A
- GIGM N/A
- P/E Ratio
- NKGN N/A
- GIGM N/A
- Revenue Growth
- NKGN N/A
- GIGM N/A
- 52 Week Low
- NKGN $0.36
- GIGM $1.23
- 52 Week High
- NKGN $5.10
- GIGM $1.50
- Technical
- Relative Strength Index (RSI)
- NKGN 32.54
- GIGM 47.68
- Support Level
- NKGN $0.36
- GIGM $1.34
- Resistance Level
- NKGN $0.40
- GIGM $1.45
- Average True Range (ATR)
- NKGN 0.06
- GIGM 0.06
- MACD
- NKGN 0.01
- GIGM -0.00
- Stochastic Oscillator
- NKGN 13.79
- GIGM 23.53
About NKGN NKGen Biotech Inc.
NKGen Biotech Inc is a biotechnology company developing cell therapies for neurodegenerative and oncological diseases based on activated NK cells. NK cells are part of the human innate immune response system that can selectively identify and destroy abnormal or diseased cells. Its product candidates are based on a proprietary manufacturing and cryopreservation process that produces SuperNKTM (SNK) cells that have shown increased activity as compared to the starting population of NK cells, based on the results of in vitro experiments performed by NKMAX, as defined by parameters such as cytotoxicity, cytokine production and activating receptor expression. SNK cells can be produced in large quantities and cryopreserved while maintaining high levels of cytotoxicity.
About GIGM GigaMedia Limited
GigaMedia Ltd is a publisher of online games. It has only one reportable segment, Digital Entertainment service. Digital Entertainment service business operates a portfolio of online games, mainly targeting online game players across Europe, and Asia, including Greater China and Southeast Asia. The company's portfolio of online games includes predominantly PC-based, non-cash gambling, or casino casual games, including MahJong and various card and table games. The company's product lines include MahJong, AkaSeka, Yume 100, Fun Vegas, and others. The company operates in Taiwan and Hong Kong.